These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10466034)

  • 1. Allergen-specific immunotherapy. Present state and directions for the future.
    Malling HJ
    Allergy; 1999; 54 Suppl 50():30-3. PubMed ID: 10466034
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergen immunotherapy: present and future.
    Finegold I
    Allergy Asthma Proc; 2007; 28(1):44-9. PubMed ID: 17390757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of allergen immunotherapy in allergic asthma.
    Zhang W; Lin C; Sampath V; Nadeau K
    Immunotherapy; 2018 Jun; 10(7):579-593. PubMed ID: 29569506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
    Fuchs T; Klimek L
    HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
    [No Abstract]   [Full Text] [Related]  

  • 5. Meta-analyses of specific immunotherapy trials.
    Calderon MA
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subcutaneous allergen-specific immunotherapy in patients with asthma and allergic rhinitis. 21st century].
    Martín JP
    Rev Alerg Mex; 2009; 56(2):27-9. PubMed ID: 19526950
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local immunotherapy is not documented for clinical use.
    Björkstén B
    Allergy; 1994 May; 49(5):299-301. PubMed ID: 8092424
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
    Scheinmann P; Pham Thi N; Karila C; de Blic J
    Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What is reliable in hyposensitization of IgE-induced diseases? Indications, contraindications, results and side effects].
    Fuchs T
    Internist (Berl); 1991 Dec; 32(12):721-8. PubMed ID: 1783514
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergic rhinitis. Outcomes of immunotherapy on symptom control.
    Cook PR
    Otolaryngol Clin North Am; 1998 Feb; 31(1):129-40. PubMed ID: 9530682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical bystander effect exerted by allergen immunotherapy: a hypothesis.
    Ciprandi G
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):62-3. PubMed ID: 25781197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM; Eigenmann PA
    J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
    [No Abstract]   [Full Text] [Related]  

  • 18. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma.
    Rossi RE; Monasterolo G
    Int J Immunopathol Pharmacol; 2005; 18(2):277-85. PubMed ID: 15888250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy.
    Lin SY; Leatherman B
    Otolaryngol Clin North Am; 2011 Jun; 44(3):753-64, x-xi. PubMed ID: 21621059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different methods of local allergen-specific immunotherapy.
    Kägi MK; Wüthrich B
    Allergy; 2002 May; 57(5):379-88. PubMed ID: 11972476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.